Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Bristol-Myers Squibb slips
Bristol sees sharper 2025 revenue drop after better-than-forecast Q4
Bristol Myers Squibb on Thursday posted better-than-expected fourth quarter earnings, but said its 2025 revenue would fall more sharply than Wall Street had forecast due to generic competition for some of its older drugs.
Bristol Myers Squibb Tops Q4 Estimates
Bristol Myers Squibb reported strong fourth-quarter earnings but its outlook for 2025 failed to meet expectations.
Bristol-Myers Squibb Stock Falls on Surprisingly Weak Guidance
Shares in Bristol-Myers Squibb fell more than 4% in premarket trading Thursday, after the drug maker gave 2025 guidance that undershot analyst expectations. Bristol expects sales of about $45.5 billion in 2025,
Bristol Myers forecasts steeper drop in 2025 revenue, shares fall
By Michael Erman and Sriparna Roy (Reuters) -Bristol Myers Squibb on Thursday said its 2025 revenue would fall more sharply than Wall Street had forecast due to generic competition for some of its older drugs,
Bristol Myers Earnings Are a ‘Tale of 2 Trends’ as Guidance Falls Short. The Stock Is Falling
Drugmaker Bristol Myers Squibb has been a standout among its big pharma peers over the past six months, scoring a share-price gain of more than 20%, while most of the group has been flat or down. Financial results the company reported early Thursday seem to validate that recent performance,
Bristol Myers misses expectations for 2025 guidance, shares fall
Bristol-Myers Squibb Company (NYSE:BMY) slid more than 2% in premarket trading Thursday after the company's guidance for 2025 missed average analyst expectations.
Bristol-Myers Squibb slips as 2025 outlook disappoints
Shares of Bristol-Myers Squibb (NYSE:BMY) traded lower in the premarket on Thursday after the pharma giant beat Street forecasts with its Q4 2024 results, but its 2025 outlook fell short of analysts’ expectations.
7h
on MSN
Doncaster & Bedford beat Bristol & Sale in cup
Championship sides Doncaster Knights and Bedford Blues both pull off surprises in the Premiership Rugby Cup with wins over ...
1d
on MSN
Woman who fired gun in Bristol Police Department lobby takes plea deal
Police said she pleaded guilty to one count of attempted first-degree assault with a firearm.Judicial Branch records show ...
14h
Bristol Motor Speedway 2025 NASCAR Track Profile
NASCAR events at Bristol Motor Speedway are two of the most anticipated racing spectacles fans see all year. The concrete ...
19h
on MSN
Pick of the stats: Bristol City v Swansea City
Bristol City are unbeaten across their past three league games against Swansea City (W2 D1), last having a longer run against ...
3d
on MSN
Two 18-year-olds, juvenile arrested in Bristol after abandoning stolen car involved in hit-and-run
Two 18-year-old men and a juvenile from New Haven were arrested in Bristol on Tuesday after abandoning a stolen vehicle ...
2d
Bristol Palin, Sarah Palin’s Daughter, Shares Update on Face Paralysis
Bristol Palin, the daughter of former Alaska governor Sarah Palin, recently posted a series of videos on Instagram ...
17h
Bristol Herald Courier customers not receiving newspapers or online e-editions
News 5 has received several calls this week about issues with newspaper and e-edition deliveries from the Bristol Herald ...
3d
on MSN
Pair arrested for drugs, gun charges in Bristol
Two men were arrested on various drugs and gun charges after they were surveyed by plain clothes officers in Bristol.
BioPharma Dive
1d
Bristol Myers, bracing for key patent losses, deepens cost-cutting plan
The pharmaceutical company plans to cut $2 billion in annual expenses by the end of 2027 through “operational efficiencies ...
1d
Bristol Myers Wallops Fourth-Quarter Earnings Views. But Shares Plummet 5%.
Bristol Myers Squibb stock tumbled Thursday on a light outlook for 2025 following a strong fourth-quarter report.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback